CORRESP Filing
PRECIGEN, INC.
Date: Sept. 17, 2025 · CIK: 0001356090 · Accession: 0000950103-25-011779
AI Filing Summary & Sentiment
File numbers found in text: 333-289719
Show Raw Text
CORRESP 1 filename1.htm September 17, 2025 VIA EDGAR TRANSMISSION U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Alan Campbell Re: Precigen, Inc. Registration Statement on Form S-3 Registration No. 333-289719 Dear Mr. Campbell: In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (File No. 333-289719) (the " Registration Statement ") of Precigen, Inc. We respectfully request that the Registration Statement be declared effective as of 4:00 P.M. Eastern Time on September 19, 2025, or as soon as practicable thereafter, or at such other time as our legal counsel, Davis Polk & Wardwell LLP, may request by a telephone call to the staff of the U.S. Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Davis Polk & Wardwell LLP, by calling Deanna Kirkpatrick at (212) 450-4135, Yasin Keshvargar at (212) 450-4839, or Arisa A. Sin at (212) 450-3198. Very truly yours, Precigen, Inc. By: /s/ Donald P. Lehr Name: Donald P. Lehr Title: Chief Legal Officer